Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Debt to Equity (2018 - 2026)

TransMedics has reported Debt to Equity over the past 8 years, most recently at $0.13 for Q4 2025.

  • For Q4 2025, Debt to Equity fell 51.5% year-over-year to $0.13; the TTM value through Dec 2025 reached $0.13, down 51.5%, while the annual FY2025 figure was $0.13, 51.5% down from the prior year.
  • Debt to Equity for Q4 2025 was $0.13 at TransMedics, down from $0.17 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.7 in Q2 2022 and troughed at $0.13 in Q4 2025.
  • A 5-year average of $0.36 and a median of $0.33 in 2021 define the central range for Debt to Equity.
  • Biggest five-year swings in Debt to Equity: soared 77.65% in 2022 and later plummeted 51.5% in 2025.
  • Year by year, Debt to Equity stood at $0.52 in 2021, then crashed by 39.61% to $0.31 in 2022, then soared by 37.42% to $0.43 in 2023, then plummeted by 39.67% to $0.26 in 2024, then plummeted by 51.5% to $0.13 in 2025.
  • Business Quant data shows Debt to Equity for TMDX at $0.13 in Q4 2025, $0.17 in Q3 2025, and $0.19 in Q2 2025.